Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eileen Dolan

Showing results (171-180 of 188) with videos related to

Pageof 19
Sort By:
Cancer Medicine|March 24, 2022
Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathyXindi Zhang, Matthew R Trendowski, Emma Wilkinson, et al.
Eclinicalmedicine|April 13, 2026
Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort studyVictoria A Sanchez, Paul C Dinh, Patrick O Monahan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset CancerM Eileen Dolan, Omar El Charif, Heather E Wheeler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2016
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset CancerRobert D Frisina, Heather E Wheeler, Sophie D Fossa, et al.
Blood|March 30, 2013
Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patientsEric R Gamazon, Jatinder K Lamba, Stanley Pounds, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer SurvivorsMohammad Abu Zaid, Paul C Dinh, Patrick O Monahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant gliomaJennifer A Quinn, James Pluda, M Eileen Dolan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2017
Variants in <i>WFS1</i> and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated OtotoxicityHeather E Wheeler, Eric R Gamazon, Robert D Frisina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2019
Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based ChemotherapyMatthew R Trendowski, Omar El-Charif, Mark J Ratain, et al.
Journal of the National Cancer Institute|June 30, 2010
Testicular cancer survivorship: research strategies and recommendationsLois B Travis, Clair Beard, James M Allan, et al.
Pageof 19

Showing results (171-180 of 188) with videos related to

Sort By:
Pageof 19
Cancer Medicine|March 24, 2022
Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathyXindi Zhang, Matthew R Trendowski, Emma Wilkinson, et al.
Eclinicalmedicine|April 13, 2026
Impact of cisplatin dose, renal function, and other factors on audiometrically-assessed ototoxicity in more than 1400 adult-onset cancer survivors from The Platinum Study: a multicentre cohort studyVictoria A Sanchez, Paul C Dinh, Patrick O Monahan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 15, 2017
Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset CancerM Eileen Dolan, Omar El Charif, Heather E Wheeler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 30, 2016
Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset CancerRobert D Frisina, Heather E Wheeler, Sophie D Fossa, et al.
Blood|March 30, 2013
Comprehensive genetic analysis of cytarabine sensitivity in a cell-based model identifies polymorphisms associated with outcome in AML patientsEric R Gamazon, Jatinder K Lamba, Stanley Pounds, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 16, 2019
Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer SurvivorsMohammad Abu Zaid, Paul C Dinh, Patrick O Monahan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Phase II trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant gliomaJennifer A Quinn, James Pluda, M Eileen Dolan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2017
Variants in <i>WFS1</i> and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated OtotoxicityHeather E Wheeler, Eric R Gamazon, Robert D Frisina, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2019
Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based ChemotherapyMatthew R Trendowski, Omar El-Charif, Mark J Ratain, et al.
Journal of the National Cancer Institute|June 30, 2010
Testicular cancer survivorship: research strategies and recommendationsLois B Travis, Clair Beard, James M Allan, et al.
Pageof 19